Site icon OncologyTube

Benefits Of Venetoclax Studies

Editor

Rod Humerickhouse M.D., Asset Strategy Leader at ABBVIE discusses Benefits Of Venetoclax Studies At The 60th ASH Annual Meeting on Dec 1, 2018.

Exit mobile version